| Product Name |
InVivoMAb anti-Venezuelan equine encephalitis virus E2 protein |
| Target |
Attenuated VEEV strains |
| source |
Purified from cell culture supernatant in an animal-free facility |
| Isotype |
Mouse IgG2c, κ |
| Reactivity |
Virus |
| Endotoxin |
≤1EU/mg (≤0.001EU/μg)
Determined by LAL assay |
| Purification |
Protein A |
| Purity |
≥95%
Determined by SDS-PAGE |
| Application |
in vivo protection against VEEV
in vitro neutralization of VEEV
Focus reduction neutralization test (FRNT)
Plasma membrane fusion-from-without (FFWO)
Inhibition of viral attachment on cells
Inhibition of viral egress
ELISA |
| Formulation |
PBS, pH 7.0
Contains no stabilizers or preservatives |
| Storage |
The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
